Publicacións en colaboración con investigadores/as de Hospital Clinic Barcelona (12)

2022

  1. Quality indicators and excellence requirements for a multidisciplinary lung cancer tumor board by the Spanish Lung Cancer Group

    Clinical and Translational Oncology, Vol. 24, Núm. 3, pp. 446-459

2017

  1. Radiation therapy in extensive stage small cell lung cancer

    Frontiers in Oncology, Vol. 7, Núm. AUG

2016

  1. Corrigendum to "Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance". [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272]

    Reports of Practical Oncology and Radiotherapy

  2. Evidence-based recommendations of postoperative radiotherapy in lung cancer from Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

    Clinical and Translational Oncology, Vol. 18, Núm. 4, pp. 331-341

  3. GRAY-B: An open label multicenter phase-2 GEM study on ipilimumab and radiation in patients with melanoma and brain metastases

    Annals of Oncology, Vol. 27, pp. vi383

  4. No role for trimodality therapy and consolidation chemotherapy compared with concurrent radiochemotherapy alone in stage III non-small-cell lung cancer

    Journal of Clinical Oncology

2015

  1. Imaging of Tumor Angiogenesis for Radiologists-Part 1: Biological and Technical Basis

    Current Problems in Diagnostic Radiology, Vol. 44, Núm. 5, pp. 407-424

  2. Imaging of Tumor Angiogenesis for Radiologists-Part 2: Clinical Utility

    Current Problems in Diagnostic Radiology, Vol. 44, Núm. 5, pp. 425-436

  3. The metabolic syndrome and its components in patients with prostate cancer on androgen deprivation therapy

    Journal of Urology, Vol. 193, Núm. 6, pp. 1963-1969

  4. Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance

    Reports of Practical Oncology and Radiotherapy, Vol. 20, Núm. 4, pp. 259-272

2013

  1. Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study

    British Journal of Cancer, Vol. 108, Núm. 12, pp. 2565-2572

2010

  1. Spanish radiobiological pattern of care in lung cancer: A GOECP/SEOR study

    Clinical and Translational Oncology, Vol. 12, Núm. 4, pp. 292-298